Alexandros Briasoulis - Publications

Phosphodiesterase-5 Inhibitor Use and Clinical Outcomes in Left Ventricular Assist Device Recipients: A Real-World Analysis of 31,465 Patients.

Journal: American journal of therapeutics

Published: September 02, 2026

Guideline directed-medical therapy for heart failure within 3 months post LVAD implant and rehospitalization.

Journal: JHLT open

Published: August 08, 2026

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 26, 2026

Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results.

Journal: Clinical cardiology

Published: June 20, 2026

Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis.

Journal: Journal of the American Heart Association

Published: June 15, 2026

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials.

Journal: JAMA cardiology

Published: June 03, 2026

Conduction system pacing as a primary strategy for cardiac resynchronization therapy in reduced ejection fraction: An updated systematic review and meta-analysis of randomized controlled trials.

Journal: Progress in cardiovascular diseases

Published: June 01, 2026

GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.

Journal: Diabetes, obesity & metabolism

Published: May 23, 2026

Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: a systematic review and network meta-analysis of randomised controlled trials.

Journal: American heart journal

Published: May 13, 2026

Improved Survival With Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Heart Failure With Preserved Ejection Fraction and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: American journal of therapeutics

Published: May 06, 2026

Sotatercept as an Add-On to Background Therapy in Idiopathic Pulmonary Arterial Hypertension: Insights from a Real-World Cohort.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 24, 2026

GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity-Matched Real-World Analysis.

Journal: Diabetes, obesity & metabolism

Published: March 23, 2026